← Leaderboards
Jane C. Weeks
Dana-Farber Cancer Institute
$11,709,158
Attributed
$13,709,674
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.8M · FY2005–13$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$24,568,214 · 9
By mechanism
U01$18,241,990 · 2
UC2$2,001,097 · 1
RC2$1,999,936 · 1
RC1$998,648 · 1
P50$620,848 · 2
R01$360,081 · 1
Top collaborators
- John Z Ayanian3 shared
- Mona N. Fouad3 shared
- David P Harrington3 shared
- Mark Christopher Hornbrook3 shared
- Katherine L Kahn3 shared
- Mary Beth Landrum3 shared
- Dawn T Provenzale3 shared
- Robert S Sandler3 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Richard D Gelber$10,116,721
- David P Harrington$7,342,089
- David J Sugarbaker$3,967,877
- Joanne Wolfe$6,388,971
- Jeffrey W Clark$0
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResearch PersonnelCohortMedical RecordsCancer CareCaringProviderVariantCommunitiesPoliciesOncologyOutcomes ResearchLeadMalignant Neoplasm Of LungFutureCostInterviewColorectal CancerRecurrenceLungPolicy MakerBreastCancer TherapyData Collection
Grant awards (26)
Comparative Effectiveness of Cancer Therapies$172,807
K05 · FY2013 · CA · contact PI
Comparative Effectiveness of Cancer Therapies$172,807
K05 · FY2012 · CA · contact PI
Cancer Care Outcomes Research and Surveillance (CanCORS)$3,111,256
U01 · FY2011 · CA
Cancer Care Outcomes Research and Surveillance (CanCORS)$4,300,267
U01 · FY2010 · CA
Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer Care$2,001,097
UC2 · FY2010 · CA · contact PI
Comparative effectiveness research using NCCN data$498,853
RC1 · FY2010 · CA · contact PI
Cancer Care Outcomes Research and Surveillance (CanCORS)$3,447,017
U01 · FY2009 · CA
Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer Care$1,999,936
RC2 · FY2009 · CA · contact PI
Comparative effectiveness research using NCCN data$499,795
RC1 · FY2009 · CA · contact PI
Cohort Studies and Databases Core$162,630
P50 · FY2009 · CA · contact PI
Cohort Studies and Databases Core$95,261
P50 · FY2008 · CA · contact PI
Lung/Colon Cancer Outcomes--Cancer Research Network$93,548
U01 · FY2008 · CA · contact PI
Lung/Colon Cancer Outcomes--Cancer Research Network$375,743
U01 · FY2007 · CA · contact PI
Developing Quality Indicators for Advanced Cancer Care$360,081
R01 · FY2007 · CA · contact PI
C-3: Cohort Studies and Databases$157,073
P50 · FY2007 · CA · contact PI
C-3: Cohort Studies and Databases$102,974
P50 · FY2006 · CA · contact PI
Lung/Colon Cancer Outcomes--Cancer Research Network$74,987
U01 · FY2006 · CA · contact PI
Lung/Colon Cancer Outcomes--Cancer Research Network$1,573,606
U01 · FY2005 · CA
C-3: Cohort Studies and Databases$102,910
P50 · FY2005 · CA
Lung/Colon Cancer Outcomes--Cancer Research Network$1,691,799
U01 · FY2004 · CA
Lung/Colon Cancer Outcomes--Cancer Research Network$1,447,412
U01 · FY2003 · CA
Lung/Colon Cancer Outcomes--Cancer Research Network$1,291,617
U01 · FY2002 · CA
Core--Clinical data and data management$0
P50 · FY2002 · CA
Lung/Colon Cancer Outcomes--Cancer Research Network$834,738
U01 · FY2001 · CA
Core--Clinical data and data management$0
P50 · FY2001 · CA
Core--Clinical data and data management$0
P50 · FY2000 · CA